Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

NCT02677974 is registered in ClinicalTrials.gov with On-X Life Technologies, Inc. as lead sponsor.

NCT NCT02677974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02677974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Lead sponsor
On-X Life Technologies, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
November 10, 2015
Completion date
August 31, 2027
Enrollment
510 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic and bleeding events